✦ LIBER ✦

Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma

✍ Scribed by Albrecht Reichle; Klaus Bross; Thomas Vogt; Frauke Bataille; Peter Wild; Anna Berand; Stefan W. Krause; Reinhard Andreesen

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 113 KB
Volume: 101
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20574

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy of a combination of etoposi

The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma

✍ Zs. Pápai; Gy. Bodoky; J. Szántó; I. Poller; P. Rahóty; S. Eckhardt; I. Láng; M. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami

Phase I clinical trial of fixed–dose rat

Phase I clinical trial of fixed–dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation

✍ José M. Buesa; Raquel Losa; Aida Fernández; Marta Sierra; Emilio Esteban; Ángela 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views